Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new site revision was added (v3.4.2) and the older entry (v3.4.1) was removed; a government funding notice shown previously is no longer present. No study content, eligibility criteria, or results were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check26 days agoChange DetectedA site-wide notice about government funding status was added and the site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check33 days agoChange DetectedAdded a Show glossary feature and updated the site revision to v3.4.0. The label for the last QC update was changed to 'Last Update Submitted that Met QC Criteria' and the 'No FEAR Act data' entry was removed.SummaryDifference0.2%

- Check40 days agoChange Detected- Removed related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' from the study page. This may affect searchability and cross-linking to related resources, but does not alter the core trial details.SummaryDifference0.2%

- Check47 days agoChange DetectedAdded related topics including Multiple Myeloma and MedlinePlus Genetics, and updated the page revision to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' related-topic section from the page.SummaryDifference0.2%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.